Sung-Hwan Cho
Algemeen Directeur bij CHOA PHARMACEUTICAL CO., LTD.
Vermogen: 2 M $ op 30-04-2024
Actieve functies van Sung-Hwan Cho
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CHOA PHARMACEUTICAL CO., LTD. | Directeur/Bestuurslid | 18-02-2002 | - |
Algemeen Directeur | - | - | |
President | - | - | |
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Algemeen Directeur | - | - |
President | - | - |
Loopbaan van Sung-Hwan Cho
Opleiding van Sung-Hwan Cho
Korea University | Undergraduate Degree |
Chung-Ang University | Graduate Degree |
Statistieken
Internationaal
Zuid-Korea | 5 |
Operationeel
President | 2 |
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Distribution Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Beurs
- Insiders
- Sung-Hwan Cho
- Ervaring